Table of Contents
ISRN Hepatology
Volume 2013 (2013), Article ID 276563, 6 pages
http://dx.doi.org/10.1155/2013/276563
Clinical Study

Metabolic Bone Disease in Viral Cirrhosis: A Prospective Study

EFD-Hepatogastroenterology Unit, Ibn Sina University Hospital, Rabat 10000, Morocco

Received 7 February 2013; Accepted 26 March 2013

Academic Editors: D. Capone and A. Castiella

Copyright © 2013 Rabia Goubraim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. I. Giouleme, T. A. Vyzantiadis, N. L. Nikolaidis et al., “Pathogenesis of osteoporosis in liver cirrhosis,” Hepato-Gastroenterology, vol. 53, no. 72, pp. 938–943, 2006. View at Google Scholar · View at Scopus
  2. J. Collier, “Bone disorders in chronic liver disease,” Hepatology, vol. 46, no. 4, pp. 1271–1278, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Paramvir Sokhi, A. Anantharaju, R. Kondaveeti, S. D. Creech, K. K. Islam, and D. H. Van Thiel, “Bone mineral density among cirrhotic patients awaiting liver transplantation,” Liver Transplantation, vol. 10, no. 5, pp. 648–653, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. H. M. Ahmed, H. K. El-Shereef, S. S. El-Gendi et al., “Leptin, osteocalcin, and bone mineral density in post-hepatitic liver cirrhosis,” Arab Journal of Gastroenterology, vol. 11, no. 3, pp. 130–135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J. D. Collier, M. Ninkovic, and J. E. Compston, “Guidelines on the management of osteoporosis associated with chronic liver disease,” Gut, vol. 50, no. 1, pp. 1–9, 2002. View at Google Scholar · View at Scopus
  6. M. M. J. Guichelaar, R. Kendall, M. Malinchoc, and J. E. Hay, “Bone mineral density before and after OLT: long-term follow-up and predictive factors,” Liver Transplantation, vol. 12, no. 9, pp. 1390–1402, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Wibaux, I. Legroux-Gerot, S. Dharancy, E. Boleslawski, N. Declerck, V. Canva et al., “Evaluation du statut osseux chez les patients en attente d’une greffe hépatique,” Revue Du Rhumatisme, vol. 78, pp. 459–464, 2011. View at Google Scholar
  8. “Assessment of fracture risk and its application to screening for postmenopausal osteoporosis,” Report of WHO Study Group 843, World Health Organ Association, Geneva, Switzerland, 1994.
  9. M. PcDuarte, M. L. F. Farias, H. S. M. Coelho et al., “Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease,” Journal of Gastroenterology and Hepatology, vol. 16, no. 9, pp. 1022–1027, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. J. George, H. K. Ganesh, S. Acharya et al., “Bone mineral density and disorders of mineral metabolism in chronic liver disease,” World Journal of Gastroenterology, vol. 15, no. 28, pp. 3516–3522, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Fekih, H. Romdhane, H. Sahli, L. Kallel, S. Matri, S. Karoui et al., “Les anomalies du métabolisme osseux au cours de la cirrhose,” Gastroentérologie Clinique et Biologique, vol. 33, no. 3, supplement 1, p. 242, 2009. View at Google Scholar
  12. A. Z. Salama, A. N. Lotfy, and H. M. El Aeizy, “Evaluation of hepatic osteodystrophy in patients with liver cirrhosis and correlation with severity of liver disease,” Arab Journal of Gastroenterology, vol. 8, no. 1, pp. 10–14, 2007. View at Google Scholar
  13. M. Javed, A. Saeed, I. M. Khan et al., “Frequency of osteoporosis in patients with cirrhosis due to hepatitis B and hepatitis C: a study of 100 cases,” Journal of Ayub Medical College, Abbottabad, vol. 21, no. 3, pp. 51–53, 2009. View at Google Scholar · View at Scopus
  14. J. L. Gonzalez-Calvin, F. Gallego-Rojo, R. Fernandez-Perez, F. Casado-Caballero, E. Ruiz-Escolano, and E. G. Olivares, “Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 9, pp. 4325–4330, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. F. J. Gallego-Rojo, J. L. Gonzalez-Calvin, M. Muñoz-Torres, J. L. Mundi, R. Fernandez-Perez, and D. Rodrigo-Moreno, “Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis,” Hepatology, vol. 28, no. 3, pp. 695–699, 1998. View at Google Scholar · View at Scopus
  16. A. Mahmoudi, J. Reboul-Marty, G. Chalès et al., “Bone mineral density assessed by dual-energy X-ray absorptiometry in patients with viral or alcoholic compensated cirrhosis. A prospective study,” Clinics and Research in Hepatology and Gastroenterology, vol. 35, no. 11, pp. 731–737, 2011. View at Publisher · View at Google Scholar
  17. A. M. Parfitt, “Morphologic basis of bone mineral measurements: transient and steady state effects of treatment in osteoporosis,” Mineral and Electrolyte Metabolism, vol. 4, no. 6, pp. 273–287, 1980. View at Google Scholar · View at Scopus
  18. S. Kanzler, M. Baumann, P. Schirmacher et al., “Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-β,” Journal of Viral Hepatitis, vol. 8, no. 6, pp. 430–437, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Ormarsdóttir, Ö. Ljunggren, H. Mallmin, H. Brahm, and L. Lööf, “Low body mass index and use of corticosteroids, but not cholestasis, are risk factors for osteoporosis in patients with chronic liver disease,” Journal of Hepatology, vol. 31, no. 1, pp. 84–90, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Ormarsdóttir, O. Ljunggren, H. Mallmin, K. Michaëlsson, and L. Lööf, “Increased rate of bone loss at the femoral neck in patients with chronic liver disease,” European Journal of Gastroenterology and Hepatology, vol. 14, no. 1, pp. 43–48, 2002. View at Publisher · View at Google Scholar
  21. G. Chalès and Guggenbuhl P. Os et foie, Encyclopédie Médico-Chirurgicale 7-034-D-85.
  22. W. D. Leslie, C. N. Bernstein, and M. S. Leboff, “AGA technical review on osteoporosis in hepatic disorders,” Gastroenterology, vol. 125, no. 3, pp. 941–966, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. M. A. Karan, N. Erten, C. Tascioglu, A. Karan, D. Sindel, and G. Dilsen, “Osteodystrophy in posthepatitic cirrhosis,” Yonsei Medical Journal, vol. 42, no. 5, pp. 547–552, 2001. View at Google Scholar · View at Scopus
  24. X. L. Bai, T. B. Liang, L. H. Wu et al., “Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases,” Transplantation Proceedings, vol. 39, no. 10, pp. 3182–3185, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. American Gastroenterological Association, “American Gastroenterological Association medical position statement: osteoporosis in hepatic disorders,” Gastroenterology, vol. 125, no. 3, pp. 937–940, 2003. View at Publisher · View at Google Scholar